Related Experiment Videos
Summary
Hydergine, a gerontopsychiatric drug, acts on dopamine and serotonin receptors. Controlled trials in senile mental impairment patients showed its effects, though clinical improvement correlation remains unestablished.
Area of Science:
- Gerontopsychiatry
- Neuropharmacology
Background:
- Hydergine is a gerontopsychiatric drug.
- It acts as an agonist at central dopamine and serotonin receptors.
Purpose of the Study:
- To review the results of controlled trials using Hydergine in patients with senile mental impairment.
- To assess the drug's efficacy using various evaluation methods.
Main Methods:
- Controlled trials involving patients with senile mental impairment.
- Assessment using the Sandoz Clinical Assessment Geriatric (SCAG) scale, psychometric tests like the Nuremberg Geriatric Inventory (NGI), and electroencephalogram (EEG).
- Monitoring of serum prolactin levels.
Main Results:
- Hydergine demonstrated effects in patients with senile mental impairment.
- The drug was evaluated using standardized scales, psychometric tests, and EEG.
- Hydergine was observed to lower serum prolactin levels.
Conclusions:
- The review summarizes Hydergine's effects in senile mental impairment.
- A direct correlation between prolactin reduction and clinical improvement has not yet been established.
- The need for objective indicators in gerontopsychiatry is emphasized.